cci 103f has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckman, W; Gill, M; Joseph, AP; Kwock, L; McMurry, HL; Raleigh, JA | 1 |
| Allen, PS; Franko, AJ; Kelly, DA; Raleigh, JA; Trimble, LA | 1 |
2 other study(ies) available for cci 103f and Prostatic Neoplasms
| Article | Year |
|---|---|
Evaluation of a fluorinated 2-nitroimidazole binding to hypoxic cells in tumor-bearing rats by 19F magnetic resonance spectroscopy and immunohistochemistry.
Topics: Adenocarcinoma; Animals; Cell Hypoxia; Evaluation Studies as Topic; Immunohistochemistry; Magnetic Resonance Spectroscopy; Male; Nitroimidazoles; Prostatic Neoplasms; Rats | 1992 |
Development of an in vivo 19F magnetic resonance method for measuring oxygen deficiency in tumors.
Topics: Adenocarcinoma; Animals; Carcinoma 256, Walker; Cell Hypoxia; Female; Magnetic Resonance Spectroscopy; Male; Nitroimidazoles; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Tritium | 1991 |